Logo

Empire Genomics Lands $1M Financing

Jul 02, 2014 | staff reporter

NEW YORK (GenomeWeb News) — Rand Capital and SCP Buffalo Incubator Innovate NY Fund said yesterday that they have invested $1 million in privately held molecular diagnostics firm Empire Genomics.

Based in Buffalo, NY, Empire Genomics offers testing products and services for cancer disease management that enable physicians to improve their diagnostic capabilities and tailor specific therapeutic treatments using patient DNA.

Empire Genomics was created in 2006 from research at Buffalo's Roswell Park Cancer Institute. The company has proprietary assays for prostate cancer and multiple myeloma, and its customers include hospitals, pharmaceutical clients, and academic centers.

The company said it will use the new funds to accelerate the pace of its growth by acquiring new technologies, growing staff, and increasing test offerings.

Filed under

Diagnostics
Molecular Diagnostics
Business News
financing
Empire Genomics
Breaking News
The Scan

Tara Pacific Expedition Project Team Finds High Diversity Within Coral Reef Microbiome

In papers appearing in Nature Communications and elsewhere, the team reports on findings from the two-year excursion examining coral reefs.

Study Examines Relationship Between Cellular Metabolism, DNA Damage Repair

A new study in Molecular Systems Biology finds that an antioxidant enzyme shifts from mitochondria to the nucleus as part of the DNA damage response.

Stem Cell Systems Target Metastatic Melanoma in Mouse Model

Researchers in Science Translational Medicine describe a pair of stem cell systems aimed at boosting immune responses against metastatic melanoma in the brain.

Open Pediatric Brain Tumor Atlas Team Introduces Genomic Data Collection, Analytical Tools

A study in Cell Genomics outlines open-source methods being used to analyze and translate whole-genome, exome, and RNA sequence data from the Pediatric Brain Tumor Atlas.